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Introduction
Dopamine is a neurotransmitter in the CNS. Dopamine receptors are classified into five subtypes, referred to as either D1-like (D1 and D5) or D2-like (D2, D3 and D4) receptors (Missale et al., 1998) . Dopamine concentration is a key factor in the activation of different receptor subtypes. In the prefrontal cortex, low concentrations of dopamine act on D1-like receptors, while higher concentrations act on D2-like receptors (Zheng et al., 1999; Trantham-Davidson et al., 2004) .
In the spinal cord, the descending dopaminergic fibre projects from the hypothalamic A11 region (Björklund and Skagerberg, 1979; Skagerberg and Lindvall, 1985; Millan, 2002; Benarroch, 2008) , and dopamine can modulate locomotion and nociception (Clemens and Hochman, 2004; Han et al., 2007; Lapointe et al., 2009) . In the rat spinal cord, dopamine at concentrations greater than 10 µM activates K + channels, producing hyperpolarization via D2-like receptors, but not D1-like receptors in substantia gelatinosa neurons, which are located in the superficial laminae of the dorsal horn receiving nociceptive inputs (Tamae et al., 2005; Taniguchi et al., 2011) . D1-like receptors are also expressed in the spinal cord (Levant and McCarson, 2001; Zhu et al., 2007) . Although it has been reported that dopamine increases AMPA currents via D1-like receptors in the mouse motoneurons (Han and Whelan, 2009) , the role of D1-like receptors in afferent transmission remains unclear.
The spinal cord isolated from neonatal rats is a widely-used preparation for investigating spinal functions and drug actions. Electrical stimulation of the dorsal root elicits a monosynaptic reflex potential (MSR) followed by a slow ventral root potential (sVRP) at the corresponding ventral root. The MSR is A fibre-evoked response mainly mediated by non-NMDA receptors. On the other hand, sVRP is C fibre-evoked polysynaptic response mediated by NMDA and various metabolic receptors such as tachykinin NK receptors in the spinal cord (Akagi et al., 1985; Nussbaumer et al., 1989; Brockmeyer and Kendig, 1995; Faber et al., 1997; Kocsis et al., 2003) . The sVRP is believed to reflect nociceptive transmission in the spinal cord based on its electrophysiological and pharmacological features (Akagi and Yanagisawa, 1987; Nussbaumer et al., 1989; Woodley and Kendig, 1991; Faber et al., 1997; Otsuguro et al., 2005) . Our laboratory previously reported that dopamine at concentrations of >1 µM depolarized the ventral root and suppressed the MSR (Kitazawa et al., 1985) . In the mouse spinal cord, dopamine depresses MSR via D2-like receptors (Clemens and Hochman, 2004) . In contrast, there is no information on the effects of dopamine on sVRP.
In the current study, the effects of dopamine on spinal cord isolated from the neonatal rat were examined. The results have demonstrated that dopamine at lower concentrations, as well as endogenous dopamine, preferentially depresses sVRP via D1-like receptors.
Methods

Spinal cord preparation
All experimental protocols were approved by the Committee on Animal Experimentation, Graduate School of Veterinary Medicine, Hokkaido University. Every effort was made to minimize animal suffering and to reduce the number of animals used.
Wistar rats (0-5 days old) of either sex were used.
Neonatal rats were euthanized by decapitation, and then the spinal cords were isolated. Isolated spinal cord preparations were prepared as previously described (Otsuguro et al., 2006; . The hemisected spinal cord from the lower thoracic through sacral regions was superfused in a recording chamber of 0.5 ml volume with artificial cerebrospinal fluid (ACSF) at a flow rate of approximately 2.5 ml min -1 . The temperature of the bath was monitored before and after each recording using a thermometer (CT-1200D, Custom, Tokyo, Japan) and was maintained at 27±2ºC. The composition of the ACSF was as follows (mM): NaCl 138; NaHCO3 21; NaH2PO4 0.6; KCl 3.5; CaCl2 1.25; MgCl2 1.2; glucose 10; gassed with 95% O2 and 5% CO2; pH~7.3.
Electrophysiological measurement
Stimulating and recording suction electrodes were placed on the dorsal and ipsilateral ventral roots (L3-L5), respectively. The dorsal root was stimulated every 2 min by a single square wave pulse (40 V, 200 µs). MSR and sVRP were recorded from the segmental ventral root, and the magnitudes of each were expressed as peak amplitude (mV) and depolarization integral (mV·s) over the resting potential of the ventral root, respectively ( Figure 1A ). The preparation was allowed to equilibrate for 1 h before recordings. In most of the experiments, the inhibitory effects of dopamine, SKF83959, SKF81297 and methamphetamine on spinal reflex potentials were evaluated by measuring the mean of three responses around their maximal effects and the data were expressed as a percentage of the mean of three responses just before application. The time course of the magnitude of the MSR and sVRP was expressed as a percentage of the mean of the first five responses. Electrical responses were detected by a high gain amplifier (MEZ-8300, Nihon Kohden, Tokyo, Japan) with low-pass filter at 10 kHz. MSR was recorded using a thermal arraycorder (WR7900, Graftec, Yokohama, Japan) with a sampling time of 80 µs. sVRP were digitized by an analog/digital converter (PowerLab, ADInstruments, Castle Hill, Australia) with a sampling time of 10 ms. Data were stored in a personal computer and analyzed with LabChart 6 software (ver. 6.0, ADInstruments).
RT-PCR
The oligonucleotide primers used for amplifying dopamine receptor subtype gene sequences (GenBank accession number) and its expected product size were as follows: 5'-ACCCTCATAGATGGGCACAG-3' (280 bp). Total RNA was extracted from the lumber region of the spinal cord and its dorsal root ganglion (DRG) using TRI Reagent (Sigma-Aldrich, Saint Louis, MO, USA) and then treated with DNase I (Invitrogen, Carlsbad, CA, USA). First strand cDNA synthesis and subsequent amplification were performed using a PrimeScript One Step RT-PCR Kit (Ver. 2, Takara Bio, Otsu, Japan). PCR reactions were preceded by incubation at 94ºC for 2 min and consisted of 94ºC for 30 s, followed by 57ºC (D2, D5 and -action), 60ºC (D4) or 65ºC (D1, D3) for 30 s, and 72ºC for 60 s for 30 (D1, D2, D5 and -actin), 34 (D3) and 36 (D4) cycles. Amplified products were separated and analyzed by 2.0% agarose gel electrophoresis containing ethidium bromide and visualized under UV light.
Measurement of dopamine and 5-HT concentration
The concentrations of dopamine and 5-HT were determined according to the method of Ito et al. (2001) with some modifications. Rat spinal cord from the lower thoracic through lumber regions was isolated from five littermates. After removal of all roots and DRGs, the spinal cord was sliced into several pieces and then they were equilibrated in ACSF for 1 h at 35°C. After incubation for 30 min with fresh ACSF, the tissues were treated for 10 min with methamphetamine (30 µM) and then incubated for an additional 30 min with fresh ACSF. Incubation media from before and after treatment with methamphetamine was stored on ice for the measurement of 5-HT. For the measurement of dopamine, the sample solution was treated with alumina to purify and concentrate the dopamine (Anton and Sayre, 1962) . Isoproterenol (1 µM) was used as an internal standard.
The samples were applied to an HPLC system with an ODS column (EICOMPAK SC-5ODC, 3.0 150 mm, EICOM, Kyoto, Japan) equipped with an electrochemical detector (ECD-300, EICOM, Kyoto, Japan). The mobile phase consisted of 100 mM citric buffer (pH 3.5), 19% methanol, 5 mg l -1 EDTA Na2 and 190 mg l -1 sodium octasulfonic acid. The flow rate was 0.5 ml min -1 . The amounts of dopamine and 5-HT were expressed relative to tissue wet weight (fmol mg -1 ).
Data analysis
Results were expressed as means±SEM. Statistical comparisons between two groups were performed by paired or unpaired Student's t-test. A P value of less than 0.05 was considered significant.
Drugs
Haloperidol was purchased from Pfizer Japan (Tokyo, Japan). (S),9(R)-(-)-Bicuculline methobromide and 5-hydroxytryptamine creatinine sulfate (5-HT) were from Sigma-Aldrich (St. Louis, MO, USA). 3-Hydroxytyramine hydrochloride (dopamine) was from Tokyo Chemical (Tokyo, Japan). dl-Isoproterenol hydrochloride and strychnine sulfate were from Wako Pure Chemical (Osaka, Japan). Ketanserin tartrate, LE300, raclopride, SCH23390 hydrochloride, SKF81297 hydrobromide and SKF83959 hydrobromide were from Tocris Bioscience (Bristol, UK). Methamphetamine hydrochloride was from Dainippon Sumitomo Pharma (Osaka, Japan). Atipamezole hydrochloride was supplied from Orion (Espoo, Finland). Naloxone hydrochloride was from Daiichi Sankyo (Tokyo, Japan). Drugs and molecular target nomenclature follows Alexander et al. (2009) .
Results
Effects of dopamine on reflex potentials in rat spinal cord
The effects of dopamine on spinal reflex potentials evoked by electrical stimulation were measured every 2 min. Bath-application of dopamine (1 µM) rapidly suppressed the sVRP without any effect on MSR ( Figure 1B ). This inhibitory effect of dopamine was often accompanied by suppression of spontaneous activity without changes in baseline ventral root potential. The dopamine-evoked depression of sVRP was maintained during application for 10 min followed by immediate recovery after washout of the drug. As shown in Figure 1C , repeated application of dopamine inhibited sVRP to the same extent (1st: 64.5±3.9%, n=6; 2nd: 64.5±3.7%, n=6).
The application of dopamine (0.01-1 µM) inhibited sVRP but not MSR, in a concentration-dependent manner without any effect on baseline potential ( Figure 2 ). As previously reported (Kitazawa et al., 1985) , at a higher concentration (3 µM), dopamine slightly suppressed MSR and depolarized the baseline ventral root potential, and this was accompanied by increases in spontaneous activity ( Figure 2B ). The concentration-response curve for sVRP inhibition by dopamine was biphasic with a first phase at concentrations of 300 nM or less and a second phase at concentration of more than 300 nM (Figure 2 C and D).
Dopamine-evoked depression of sVRP was mediated by D1-like receptors
The expression of dopamine receptor subtypes in the spinal cord and DRG of neonatal Dopamine-evoked depression of sVRP was also attenuated by LE300 (5 µM), another D1-like receptor antagonist ( Figure 4B ). Although treatment with raclopride (5 µM), a D2-like receptor antagonist, also resulted in a significant decrease of the dopamine-evoked depression of sVRP, haloperidol (1 µM), another D2-like receptor antagonist, had no effect on it ( Figure 4C ). LE300, haloperidol and raclopride had no effect on MSR (data not shown). These results suggested that D1-like receptors are involved in sVRP inhibition in response to dopamine. It was next examined whether the effect of dopamine on the spinal cord was mimicked by SKF83959 and SKF81297, D1-like receptor agonists. Similar to dopamine, SKF83959 (1 µM) and SKF81297 (1µM) suppressed the sVRP without any effects on MSR ( Figure 5A and B) or baseline ventral root potential. Inhibition of sVRP in responses to SKF83959 was also effectively decreased by SCH23390 ( Figure 5C and D). Unlike dopamine, however, the effect of SKF81297 was irreversible until 1 hr after washout (data not shown). Therefore, we examined the effect of SCH23390 on SKF81297-evoked depression in separate preparations. Inhibition of sVRP in response to SKF81297 was abolished by SCH23390 ( Figure 5D ).
Characterization of dopamine-evoked depression of sVRP
Several reports have indicated that dopamine enhances inhibitory transmissions such as those mediated by GABA and glycine in the CNS (Porras and Mora, 1993; Radnikow and Misgeld, 1998; Seamans et al., 2001; Trantham-Davidson et al., 2004) . We next examined the effects of bicuculline and strychnine, GABAA and glycine receptor antagonists, respectively, on sVRP inhibition in response to dopamine (Figure 6 ). Since strychnine and bicuculline markedly increased the amplitude of the sVRP, the inhibitory effect of dopamine was evaluated as a percentage of the responses just before the first application. Strychnine (0.5 µM) increased sVRP to 130.6±0.4% (n=6). In the presence of strychnine, dopamine (1µM) decreased sVRP by 18.7±0.4% (n=6), which was less than the control (38.0±2.8%, n=6, P<0.01, paired Student's t-test). Bicuculline (3 µM) also increased sVRP to 188.2±20.4% (n=6). In the presence of bicuculline, dopamine decreased sVRP by 21.2±5.6% (n=6), which was not significantly different from the control (34.5±2.2%, n=6). Naloxone (1 µM), an opioid receptor antagonist, also increased sVRP to 117.4±3.7% (n=6). Dopamine-evoked depression of sVRP (41.3±2.8% inhibition, n=6) was unaffected by naloxone (42.7±7.7% inhibition, n=6).
Methamphetamine-evoked depression of reflex potentials via dopamine and 5-HT release
To investigate the effect of endogenous dopamine on the spinal cord, the spinal cord preparations were treated with methamphetamine, an endogenous dopamine releaser. Repeated application of methamphetamine (10 µM) for 10 min after an interval of 40 min depressed reflex potentials to the same extent for MSR (1st: 57.1±12.0%; 2nd: 52.8±11.6%, n=6) and sVRP (1st: 61.6±9.3%; 2nd: 55.8±11.5%, n=6). As shown in Figure. 8, the inhibition of sVRP by methamphetamine was attenuated by the D1-like receptor antagonists SCH23390 (1 µM) and LE300 (5 µM) but not by the D2-like receptor antagonists haloperidol (1 µM) and raclopride (5 µM). On the other hand, the depression of MSR by methamphetamine was abolished by LE300 and attenuated by haloperidol but not by raclopride (Figure 9 ). We could not analyze the effect of SCH23390 on methamphetamine-evoked depression of MSR because SCH23390 by itself depressed the MSR as mentioned above.
In addition to dopamine, methamphetamine releases other monoamines such as 5-HT and noradrenaline (Ono and Fukuda, 1984; Seiden et al., 1988; Ono et al., 1991; Fleckenstein et al., 2000) . Therefore, the effects of ketanserin, a 5-HT2A/2C receptor antagonist, and atipamezole, an 2 adrenoceptor antagonist, on MSR inhibition in response to methamphetamine were examined. Ketanserin (1 µM) inhibited the methamphetamine-evoked depression of MSR but not sVRP (Figure 10 ), while atipamezole (1 µM) had no effect on the depression of either reflex potentials by methamphetamine. Ketanserin and atipamezole by themselves had no effect on MSR and sVRP (data not shown). We also examined whether methamphetamine induced the release of these monoamines from the spinal cord. As shown in Figure 11 , methamphetamine (30 µM) significantly increased the release of dopamine and 5-HT.
The amount of 5-HT release was 5 or more times greater than that of dopamine release.
These results suggest that methamphetamine releases 5-HT and dopamine, which depresses MSR and sVRP, respectively.
Discussion and conclusions
In the current study, dopamine depressed sVRP in the isolated spinal cords of neonatal rats via the activation of D1-like receptors. Methamphetamine also depressed sVRP through the release of endogenous dopamine. These effects are suggested to contribute to functional regulation of spinal cord by dopamine released from the descending fibre.
It has been reported that at a concentration of 1 µM, dopamine depresses the MSR, representing monosynaptic transmission evoked by an A fibre activation, in the mouse spinal cord via D2-like receptors (Clemens and Hochman, 2004) ; at higher concentrations (>1 µM), dopamine depolarizes baseline ventral root potential and depresses MSR in the rat spinal cord (Kitazawa et al., 1985) . As shown in the current study, in addition to the inhibition of MSR, lower concentrations (<1 µM) of dopamine depressed sVRP without any effects on MSR and baseline level potential.
Methamphetamine, an endogenous dopamine releaser, also depressed sVRP. Inhibition by both agents was reversed by the D1-like receptor antagonists. Moreover, the D1-like receptor agonists mimicked the inhibitory effect of dopamine on sVRP. Taken together, these results indicate that endogenous dopamine effectively depresses sVRP via D1-like receptors. Raclopride, a D2-like receptor antagonist, slightly decreased the effect of dopamine, implying the additional contribution of D2-like receptors to the depression.
However, it is unlikely that D2-like receptors are mainly contributed to the inhibition by low concentrations (<1 µM) of dopamine because the methamphetamine-evoked depression was only slightly decreased by raclopride. In addition, another D2-like receptor antagonist, haloperidol, failed to attenuate both the dopamine-and methamphetamine-evoked sVRP depression. On the other hand, in the presence of SCH23390, the inhibitory effect of SKF81297 on sVRP was abolished, while the effect of dopamine was partially remained. These results also suggest the contribution of distinct receptors from D1-and D2-like receptors to the effects of dopamine. Further investigation is needed to determine these receptors.
The depression of sVRP by dopamine suggests an antinociceptive effect on the spinal cord, as sVRP is believed to reflect C-fibre-evoked nociceptive transmission (Akagi et al., 1985; Faber et al., 1997) , which can be depressed by analgesics such as opioids or 2-adrenoceptor agonists (Yanagisawa et al., 1984; Nussbaumer et al., 1989; Kendig et al., 1991; Faber et al., 1998; Otsuguro et al., 2005) . However, in pain tests in vivo, the antinociceptive effects of D1-like receptors are inconsistent. In the mouse (Zarrindast et al., 1999) and rat formalin test (Munro, 2007) , systemic administration of D1-like receptor agonists preferentially suppressed nociceptive behavior in phase II (chronic pain) compared to phase I (acute pain), while D2-like receptor agonists were effective in both phases. On the other hand, dopamine or its analogues have been shown to cause antinociception via D2-like but not D1-like receptors in the rat tail-flick test (Barasi and Duggal, 1985; Liu et al., 1992) Unlike dopamine and the D1-like receptor agonists, methamphetamine depressed sVRP and MSR to a similar extent. The depression of MSR was inhibited by dopamine receptor antagonists (LE300 and haloperidol). However, it is unlikely that dopamine is involved in this effect because MSR was not inhibited by dopamine and the D1-like receptor agonists at concentrations that inhibited sVRP. The depression of MSR was inhibited by ketanserin, a 5-HT2A/2C antagonist, but not by raclopride, a selective D2-like receptor antagonist. Methamphetamine releases not only dopamine but also 5-HT (Azzaro and Rutledge, 1973; Seiden et al., 1988; Higuchi et al., 2008) , and this was also the case in the current study. The higher concentration of 5-HT than dopamine may be due to the extensive projection of serotonergic fibres throughout the spinal cord (Millan, 2002) . In addition, it has also been reported that 5-HT depresses MSR in the rat spinal cord (Yomono et al., 1992; Wallis et al., 1993) . It seems likely, therefore, that 5-HT released by methamphetamine inhibited MSR in the neonatal rat spinal cord. The inhibitory effects of SCH23390 on MSR may be mediated via serotonergic mechanisms because of its agonistic effects for serotonergic systems (Briggs et al., 1991; Millan et al., 2001; Zarrindast et al., 2011) . Ketanserin is a 5-HT2A/2C receptor antagonist (Hartman and Northup, 1996) . In addition, the demonstrated affinities of LE300 and haloperidol to 5-HT2A receptors (Fontenla et al., 1994; Seeman and Tol, 1994 sVRP is evoked by transmission from primary afferent fibres to motoneurons via interneurons. These neuronal activities are modulated by inhibitory inputs (Akagi and Yanagisawa, 1987; Nussbaumer et al., 1989) , a process in which GABAergic and glycinergic interneurons play a key role (Akagi and Yanagisawa, 1987; Otsuguro et al., 2006) . There are several possible mechanisms of D1-like receptor-evoked sVRP inhibition, including presynaptic inhibition of excitatory transmitter release, presynaptic facilitation of inhibitory transmitter release, and postsynaptic inhibition.
Our results showed that D1-like receptor mRNA are expressed in the spinal cord but not in the DRG, suggesting that dopamine inhibits sVRP by acting on interneurons and/or motoneurons but not by inhibiting excitatory transmitter release from the endings of primary afferents.
Endogenous opioids have been implicated in spinal antinociception by dopamine (Kang et al., 1998; Hu et al., 1999) . However, in the current study, blocking of opioid receptors did not affect the depression of sVRP. D1-like receptors stimulate adenylyl cyclase (Missale et al., 1998) . On the other hand, D1-like receptors also stimulate phospholipase C (Undie and Friedman, 1990) , and SKF83959 has been reported to selectively activate phosphatidylinositol (PI)-linked D1-like receptors in the rat brain (Jin et al., 2003; Chu et al., 2010) . Therefore, PI response may be involved in A B
